Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Paramedic Training VR Nearly Doubles Students' Understanding of Teamwork in Medicine. 2022-05-31 21:00
I-Mab Announces Completion of Patient Enrollment in Phase III Clinical Trial of Eftansomatropin alfa for Treatment of Pediatric Growth Hormone Deficiency 2022-05-31 20:00
Volition Achieves CE Mark for Nu.Q® NETs Test 2022-05-31 20:00
GBM AGILE OPENS TO PAXALISIB IN EUROPE 2022-05-31 19:20
Illuccix® Granted Transitional Pass-Through Payment Status 2022-05-31 19:00
Latest Results from AENEAS Study of Hansoh Pharma's Ameile® Published in Top International Academic Journal JCO 2022-05-31 17:56
AffaMed Therapeutics Announces First Patient Dosed in the US Phase 1 Clinical Trial of AM712 in Retinal Disease 2022-05-31 11:30
Nature Cancer Publishes the Collaborative Study Results by Transcenta and Shanghai Jiao Tong University Scientists 2022-05-31 08:08
Weiyun AI & Robotics Group Attended The Annual Meeting of AAO with Its AI SMILE New Breakthough, Shows Its Leading Power in Industrial AI of Dental Medicine 2022-05-30 22:15
The Global Fight Against Monkeypox: Zelixir Biotech Predicts Monkeypox Protein Structures 2022-05-30 18:36
InxMed IN10018 at ASCO 2022 demonstrates robust efficacy in patients with platinum-resistant recurrent ovarian cancer 2022-05-30 08:10
IASO Biotherapeutics' Equecabtagene Autoleucel, the World's First CAR-T for Treatment of NMOSD, Receives IND Application Acceptance by NMPA 2022-05-28 19:33
Jacobio will Present Phase I Clinical Data of KRAS G12C Inhibitor JAB-21822 at the 2022 ASCO Annual Meeting 2022-05-28 00:22
Asieris to present a study protocol of APL-1202 in combination with BeiGene's tislelizumab as neoadjuvant therapy（NAC）for muscle invasive bladder cancer (MIBC) patients at 2022 ASCO annual meeting 2022-05-27 22:16
ASCO | OriCell Therapeutics Announces Oral Presentation at 2022 ASCO Annual Meeting Detailing Results from Phase I POLARIS Study of OriCAR-017 2022-05-27 21:49
Dizal to Demonstrate the Strength and Rapid Acceleration of its Clinical Portfolio at ASCO 2022 2022-05-27 18:00
ASCO 2022 | Ascentage Pharma Presents Updated Results from Multiple Clinical Studies Demonstrating Rapid Progress in Global Clinical Development 2022-05-27 10:02
New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment 2022-05-27 08:30
I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab 2022-05-27 05:01
Portfolio Highlights: Clinical and Financing Updates of Anji, AIxplorerBio, Domain, VivaVision, ArrePath, QurAlis and Apeiron 2022-05-26 23:53
1 156 157 158 159 160 812